CHARLES SCHWAB INVESTMENT MANAGEMENT INC - RAPT THERAPEUTICS INC ownership

RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 1 filers reported holding RAPT THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of RAPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$3,686,133
-0.4%
221,789
+12.1%
0.00%0.0%
Q2 2023$3,699,702
+3.4%
197,845
+1.5%
0.00%0.0%
Q1 2023$3,577,626
+5.6%
194,966
+13.9%
0.00%0.0%
Q4 2022$3,389,503
-15.4%
171,187
+2.8%
0.00%0.0%
Q3 2022$4,006,000
+44.0%
166,487
+9.2%
0.00%0.0%
Q2 2022$2,782,000
-13.3%
152,418
+4.5%
0.00%0.0%
Q1 2022$3,207,000
-38.6%
145,818
+2.6%
0.00%
-50.0%
Q4 2021$5,219,000
+19.9%
142,073
+1.4%
0.00%
+100.0%
Q3 2021$4,352,000
+69.5%
140,134
+73.5%
0.00%0.0%
Q2 2021$2,568,000
+75.2%
80,760
+22.4%
0.00%0.0%
Q1 2021$1,466,000
+11.8%
66,003
-0.5%
0.00%0.0%
Q4 2020$1,311,000
-37.7%
66,345
+1.4%
0.00%0.0%
Q3 2020$2,106,000
+40.2%
65,397
+26.4%
0.00%0.0%
Q2 2020$1,502,000
+138.0%
51,756
+74.7%
0.00%
Q1 2020$631,000
+40.8%
29,632
+82.9%
0.00%
Q4 2019$448,00016,1970.00%
Other shareholders
RAPT THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Column Group LLC 2,680,621$44,551,92129.58%
GREAT POINT PARTNERS LLC 1,458,070$24,233,1234.41%
Euclidean Capital LLC 1,315,798$21,868,5622.39%
Trustees of Columbia University in the City of New York 73,383$1,219,6252.24%
KINGDON CAPITAL MANAGEMENT, L.L.C. 805,828$13,392,8611.54%
Perceptive Advisors 1,920,658$31,921,3361.06%
Deep Track Capital, LP 1,500,000$24,930,0000.96%
Cheyne Capital Management (UK) LLP 20,000$332,4000.96%
Alphabet Inc. 540,270$8,979,2870.58%
BRAIDWELL LP 1,082,512$17,991,3490.57%
View complete list of RAPT THERAPEUTICS INC shareholders